» Articles » PMID: 37479705

Growth Exponents Reflect Evolutionary Processes and Treatment Response in Brain Metastases

Abstract

Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple animal models with bounded-growth dynamics accurately. However, results for the growth of human cancers in patients are scarce. Our study mined a large dataset of 1133 brain metastases (BMs) with longitudinal imaging follow-up to find growth laws for untreated BMs and recurrent treated BMs. Untreated BMs showed high growth exponents, most likely related to the underlying evolutionary dynamics, with experimental tumors in mice resembling accurately the disease. Recurrent BMs growth exponents were smaller, most probably due to a reduction in tumor heterogeneity after treatment, which may limit the tumor evolutionary capabilities. In silico simulations using a stochastic discrete mesoscopic model with basic evolutionary dynamics led to results in line with the observed data.

Citing Articles

Mathematical Model of CAR T-Cell Therapy for a B-Cell Lymphoma Lymph Node.

Sabir S, Leon-Triana O, Serrano S, Barrio R, Perez-Garcia V Bull Math Biol. 2025; 87(3):40.

PMID: 39918662 PMC: 11805830. DOI: 10.1007/s11538-025-01417-1.


Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.

Ocana-Tienda B, Leon-Triana O, Perez-Beteta J, Jimenez-Sanchez J, Perez-Garcia V PLoS Comput Biol. 2024; 20(1):e1011400.

PMID: 38289964 PMC: 10857744. DOI: 10.1371/journal.pcbi.1011400.

References
1.
Orozco J, Knijnenburg T, Manughian-Peter A, Salomon M, Barkhoudarian G, Jalas J . Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018; 9(1):4627. PMC: 6219520. DOI: 10.1038/s41467-018-06715-y. View

2.
Jiang T, Yan Y, Zhou K, Su C, Ren S, Li N . Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma. NPJ Precis Oncol. 2021; 5(1):6. PMC: 7881241. DOI: 10.1038/s41698-021-00151-w. View

3.
Marusyk A, Polyak K . Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2009; 1805(1):105-17. PMC: 2814927. DOI: 10.1016/j.bbcan.2009.11.002. View

4.
Wang H, Ou Q, Li D, Qin T, Bao H, Hou X . Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036). Cancer. 2019; 125(20):3535-3544. DOI: 10.1002/cncr.32372. View

5.
Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos J, Hlatky L . Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol. 2014; 10(8):e1003800. PMC: 4148196. DOI: 10.1371/journal.pcbi.1003800. View